- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01584271
Study of Ear Comfort Ear Drops to Treat AOE Cases Compared to DexOtic & Otidin(R)
Phase II 3 Arm Double Blinded Clinical Study Evaluating the Pain Killing and Healing Time of Botanical Ear Drops, Ear Comfort(TM), in Severe External Ear Infection (AOE) Patients, Compared to Dex-Otic(R) and Otidin(R)
Phase II 3 arm double blinded clinical study, to evaluate pain killing and healing time of Botanical Ear Drops, Ear Comfort™, in Severe External Ear Infection (AOE) patients in comparison to Dex-Otic® and Otidin®.
Study Outcome (hypothesis): if Ear Comfort™ proves to perform as well as Dex-Otic, then ENT's and family doctors will have a botanical non-antibiotic product that does not promote the formation of antibiotic-resistant infections and may be given to anti-biotics sensitive patients.
Ear comfort™ is pharmacologically stable for at least 3 years on the shelves.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Gedera, Israel
- Recruiting
- "Maccabi" Clinic
-
Contact:
- Dan Guttman, MD
- Phone Number: 972 52 7777730
- Email: dan1966@netvision.net.il
-
Principal Investigator:
- Dan Guttman, ENT MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with AOE.
- AOE patient determined by ear canal obstruction, exudates and pain.
- Males and Females between 18 and 65 years of age.
- Patients willing to refrain from using any ear drops products for the entire duration of the study. - - Subjects are willing to use the full 4 steps protocol
- Written informed consent has been obtained.
Exclusion Criteria:
- Known allergy or sensitivity to Chamomile extract or essential oils.
- Injury to tympanic membrane.
- Medical or psychiatric conditions that affect the patient's ability to give informed consent, or complete the study.
- Pregnant or lactating females.
- Use of ear drops or antibiotic or analgesic medications within the last 4 weeks prior to enrolment to the study.
- Other known diseases, including severe allergy, chronic liver or kidney disease, malignancy or contagious diseases, such as HIV or hepatitis.
- Alcohol or drug abuse, according to assessment by the investigator.
- Participation in other clinical trial within the last 30 days.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 2 Dex-Otic ear drops
Dex-Otic(R) ear drops are used for pain relief and treating ears of AOE patients.
It contains: Dexamethasone Sodium Phosphate 1 mg; Neomycin sulfate 5 mg; Polymyxin B sulfate 10,000 units.
It
|
Ear Comfort(TM): active ingredients - Thyme essential oil & Camomile extract. Inactive ingredients: anhydrous glycerin and a small quantity of surfactant. Dex-Otic(R): Dexamethasone sodium phosphate 1mg; neomycin sulfate 5mg; polymixin B sulfate 10,000 units. Inactive ingredients: propylene glycol, sodium acetate anhydrous, phenyl mercuric acetate, purified water. Otidin(R): Tetracaine HCL 0.5%; antipyrine 5% in anhydrous glycerin.
Other Names:
|
Experimental: 3 Ear Comfort(TM) ear drops
Natural Ear comfort(TM) ear drops contains Chamomile extract and Thyme oil in anhydrous glycerin for pain relief and ear healing.
|
Ear Comfort(TM): active ingredients - Thyme essential oil & Camomile extract. Inactive ingredients: anhydrous glycerin and a small quantity of surfactant. Dex-Otic(R): Dexamethasone sodium phosphate 1mg; neomycin sulfate 5mg; polymixin B sulfate 10,000 units. Inactive ingredients: propylene glycol, sodium acetate anhydrous, phenyl mercuric acetate, purified water. Otidin(R): Tetracaine HCL 0.5%; antipyrine 5% in anhydrous glycerin.
Other Names:
|
Active Comparator: 1 Otidin(R) ear drops
Otidin(R): Ear drops containing Tetracaine HCL 0.5%; antipyrine 5% in anhydrous glycerin for pain relief in AOE patients.
|
Ear Comfort(TM): active ingredients - Thyme essential oil & Camomile extract. Inactive ingredients: anhydrous glycerin and a small quantity of surfactant. Dex-Otic(R): Dexamethasone sodium phosphate 1mg; neomycin sulfate 5mg; polymixin B sulfate 10,000 units. Inactive ingredients: propylene glycol, sodium acetate anhydrous, phenyl mercuric acetate, purified water. Otidin(R): Tetracaine HCL 0.5%; antipyrine 5% in anhydrous glycerin.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ear Comfort(TM) kills pain in AOE patients within how many hours?
Time Frame: 12 months
|
Comparing Ear Comfort(TM) botanical ear drops performance in killing pain in AOE patients to Dex-Otic and Otidin Will be measured by Pain Scores on the Visual Analog Scale.
The patients will score their pains on a patient's diary document.
A professional medical statitician expert will make the anlysis.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Does Ear Comfort(TM) heal the inflamation in AOE patients?
Time Frame: 12 months
|
Performance of Ear Comfort(TM) ear drops, Dex-Otic and Otidin in healing AOE patients ear will be measured by: - reducing microbiological load, patient's compliance and ENT expert/s check of the year during the treatment period and 7 days after stopping the treatment.
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Dan Guttman, MD, Maccabi Healthcare Services, Israel
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2011058
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Otitis Externa
-
Alcon ResearchCompleted
-
Alcon ResearchCompleted
-
ShireCompleted
-
Exela Pharma Sciences, LLC.CompletedComparative Efficacy and Safety of Ciprofloxacin 0.3% and Dexamethasone 0.1% in Acute Otitis ExternaAcute Otitis ExternaUnited States, Puerto Rico
-
SalvatCompletedAcute Otitis ExternaSpain
-
ShireTerminated
-
Lee's Pharmaceutical LimitedUnknownAcute Otitis ExternaChina
-
DermaGen ABPergamum ABCompletedAcute Otitis ExternaSweden
-
Otonomy, Inc.CompletedAcute Otitis Externa | Swimmer's EarUnited States, Canada
-
Emory UniversityChildren's Healthcare of Atlanta; Georgia Institute of TechnologyCompletedAcute Otitis Externa | Acute Otitis MediaUnited States
Clinical Trials on Natural Ear Comfort(TM), a botanical ear drops product
-
Deraya UniversityMinia UniversityCompleted